<

 
Data updated 2026-04-02 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date20884269.0 (espacenet)  (Federated)  (European Patent Register), 20201104
Patent/reg. no. and dateDK/EP 4054584, 20250709
Publication date20220914
Priority no. and dateUS 201962930860 P, 20191105
EP pub. no. and date EP 4054584 20220914
Effective date
Applicant/ownerResverlogix Corp., 300, 4820 Richard Road SW
Calgary, AB T3E 6L1, CA
Applicant ref. no.24394DK00
InventorHALLIDAY, Christopher Ross Armstrong, 403 138 18 Avenue SE
Calgary, AB T2G 5P9, CA,
KHAN, Aziz Naeem, 317 - 5115 Richard Road SW
Calgary, AB T3E 7M7, CA,
LEBIODA, Kenneth Eugene, 216 Elbow Ridge Haven
Calgary, AB T3Z 3T2, CA
RepresentativeInspicos P/S, Strandvejen 60 , 2900 Hellerup, DK
Opponent
IPC ClassA61K 31/517 (2006.01) , A61K 31/70 (2006.01) , A61K 31/7042 (2006.01) , A61K 31/7048 (2006.01) , A61K 45/06 (2006.01) , A61P 9/00 (2006.01) , C07D 239/91 (2006.01) 
TitleMethods of treatment and/or prevention of major adverse cardiovascular events (MACE) with a combination of a BET bromodomain inhibitor and a sodium dependent glucose transport 2 inhibitor
Int. application no.IB2020000912
Int. publication no.WO2021090061
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact